Pseudo-dementia caused by metformin-induced vitamin B12 deficiency
Abstract
Metformin is the most widely used oral insulin-sensitizing agent. There is a significant association between long-term metformin therapy and an increased prevalence of vitamin B12 deficiency. Vitamin B12 deficiency is one of the causes of pseudo-dementia. This paper presents a rare case of pseudo-dementia in a 60-year-old Caucasian woman caused by vitamin B12 deficiency induced by the use of metformin, a vegetarian diet, and smoking. In diabetics with cognitive disorders who are on biguanide therapy, it is necessary to determine the level of vitamin B12 in the serum in order to rule out possible pseudo-dementia and to avoid possible hematological and neurological disorders. Unfortunately, vitamin B12 deficiency remains frequently unrecognized in those patients.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Metformin as an adjuvant in breast cancer treatment
- Metformin Lysosomal Targeting: A Novel Aspect to Be Investigated for Metformin Repurposing in Neurodegenerative Diseases?
- Aberrant HSF1 signaling activation underlies metformin amelioration of myocardial infarction in mice
- Metformin induces ZFP36 by mTORC1 inhibition in cervical cancer-derived cell lines
- Protein Interaction Network for Identifying Vascular Response of Metformin (Oral Antidiabetic)
- Preventing Long COVID With Metformin
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.